| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rickettsia | 8 | 2019 | 101 | 3.48 | Why? |
| Genome, Bacterial | 15 | 2019 | 446 | 3.45 | Why? |
| Kingella kingae | 5 | 2018 | 15 | 3.06 | Why? |
| Actinobacteria | 6 | 2019 | 87 | 2.71 | Why? |
| Neisseriaceae Infections | 5 | 2018 | 21 | 2.51 | Why? |
| RNA, Ribosomal, 16S | 27 | 2019 | 793 | 2.39 | Why? |
| Osteomyelitis | 7 | 2017 | 131 | 2.36 | Why? |
| Vaginosis, Bacterial | 7 | 2019 | 51 | 2.36 | Why? |
| Bacterial Typing Techniques | 17 | 2019 | 273 | 2.15 | Why? |
| Base Composition | 22 | 2019 | 203 | 2.12 | Why? |
| DNA, Bacterial | 28 | 2019 | 835 | 1.84 | Why? |
| Phylogeny | 36 | 2021 | 13341 | 1.47 | Why? |
| Sequence Analysis, DNA | 16 | 2019 | 2830 | 1.21 | Why? |
| Bacteria | 12 | 2021 | 1897 | 1.20 | Why? |
| Fatty Acids | 15 | 2019 | 238 | 1.20 | Why? |
| Bacillaceae | 3 | 2018 | 10 | 1.14 | Why? |
| Endocarditis, Bacterial | 4 | 2017 | 344 | 1.09 | Why? |
| Bacterial Proteins | 6 | 2018 | 1318 | 1.05 | Why? |
| Endocarditis | 4 | 2019 | 368 | 1.00 | Why? |
| Feces | 9 | 2019 | 4235 | 0.93 | Why? |
| Gastrointestinal Microbiome | 11 | 2019 | 1961 | 0.93 | Why? |
| Arthritis, Infectious | 3 | 2017 | 111 | 0.91 | Why? |
| Tuberculosis, Osteoarticular | 2 | 2017 | 16 | 0.88 | Why? |
| Bartonella quintana | 3 | 2017 | 27 | 0.87 | Why? |
| Bacteroidetes | 2 | 2018 | 36 | 0.86 | Why? |
| Bacterial Infections | 8 | 2019 | 2229 | 0.82 | Why? |
| Multilocus Sequence Typing | 2 | 2018 | 264 | 0.81 | Why? |
| Vaginal Discharge | 1 | 2019 | 9 | 0.80 | Why? |
| Clostridiales | 1 | 2019 | 24 | 0.79 | Why? |
| Coxiella | 1 | 2018 | 6 | 0.78 | Why? |
| Bartonella | 2 | 2018 | 24 | 0.78 | Why? |
| Anaplasmataceae | 1 | 2018 | 14 | 0.78 | Why? |
| Malate Dehydrogenase | 1 | 2018 | 3 | 0.77 | Why? |
| Chlamydiales | 1 | 2018 | 21 | 0.75 | Why? |
| Genotyping Techniques | 2 | 2021 | 360 | 0.75 | Why? |
| Oropharynx | 2 | 2017 | 1581 | 0.74 | Why? |
| Firmicutes | 4 | 2018 | 41 | 0.73 | Why? |
| Kingella | 1 | 2017 | 6 | 0.71 | Why? |
| Clostridiaceae | 1 | 2017 | 2 | 0.70 | Why? |
| Ixodidae | 1 | 2017 | 37 | 0.70 | Why? |
| Ribotyping | 1 | 2017 | 54 | 0.70 | Why? |
| Epiphyses | 1 | 2017 | 6 | 0.69 | Why? |
| Culture Techniques | 1 | 2017 | 36 | 0.69 | Why? |
| DNA, Ribosomal | 6 | 2019 | 112 | 0.69 | Why? |
| Prosthesis-Related Infections | 2 | 2018 | 302 | 0.69 | Why? |
| Staphylococcus | 1 | 2017 | 77 | 0.67 | Why? |
| France | 28 | 2021 | 12074 | 0.67 | Why? |
| Bacterial Toxins | 2 | 2017 | 185 | 0.64 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.64 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2017 | 115 | 0.60 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.59 | Why? |
| Mycobacterium | 1 | 2017 | 143 | 0.57 | Why? |
| Family Health | 1 | 2020 | 731 | 0.55 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.54 | Why? |
| Virulence | 2 | 2018 | 2172 | 0.53 | Why? |
| Cytosol | 5 | 2019 | 77 | 0.52 | Why? |
| Whole Genome Sequencing | 3 | 2021 | 3239 | 0.51 | Why? |
| Vagina | 5 | 2019 | 327 | 0.51 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.50 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.47 | Why? |
| Q Fever | 3 | 2019 | 130 | 0.47 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.47 | Why? |
| Gastrointestinal Tract | 2 | 2017 | 1113 | 0.45 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2021 | 11367 | 0.44 | Why? |
| Gram-Positive Bacterial Infections | 3 | 2019 | 323 | 0.42 | Why? |
| Genes, Bacterial | 3 | 2017 | 207 | 0.41 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.41 | Why? |
| Molecular Diagnostic Techniques | 6 | 2018 | 4239 | 0.40 | Why? |
| Coxiella burnetii | 3 | 2019 | 120 | 0.40 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.39 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.38 | Why? |
| Chryseobacterium | 2 | 2019 | 16 | 0.38 | Why? |
| Evolution, Molecular | 3 | 2018 | 3691 | 0.38 | Why? |
| Gram-Negative Bacterial Infections | 3 | 2018 | 398 | 0.37 | Why? |
| Cluster Analysis | 6 | 2019 | 3001 | 0.37 | Why? |
| Nasopharynx | 6 | 2021 | 10224 | 0.37 | Why? |
| Communicable Diseases, Emerging | 3 | 2018 | 2523 | 0.37 | Why? |
| Genomics | 7 | 2019 | 3118 | 0.36 | Why? |
| Sodium Chloride | 3 | 2018 | 203 | 0.35 | Why? |
| Rickettsia Infections | 2 | 2018 | 58 | 0.35 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.35 | Why? |
| Blotting, Western | 2 | 2021 | 863 | 0.35 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.33 | Why? |
| Infant | 14 | 2021 | 30274 | 0.33 | Why? |
| Malnutrition | 1 | 2017 | 932 | 0.33 | Why? |
| Blood Culture | 3 | 2019 | 308 | 0.33 | Why? |
| Polymerase Chain Reaction | 11 | 2020 | 6740 | 0.33 | Why? |
| Bacteria, Anaerobic | 2 | 2018 | 20 | 0.30 | Why? |
| Bacteriological Techniques | 2 | 2018 | 239 | 0.29 | Why? |
| Antigens, Surface | 1 | 2006 | 181 | 0.28 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.27 | Why? |
| Humans | 91 | 2021 | 930598 | 0.26 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.26 | Why? |
| Molecular Epidemiology | 2 | 2021 | 1638 | 0.26 | Why? |
| Senegal | 3 | 2018 | 283 | 0.26 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.26 | Why? |
| Child | 19 | 2021 | 70012 | 0.26 | Why? |
| Genome Size | 2 | 2019 | 38 | 0.24 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.24 | Why? |
| Staphylococcus aureus | 2 | 2019 | 844 | 0.23 | Why? |
| Congo | 2 | 2018 | 131 | 0.23 | Why? |
| Homeless Persons | 3 | 2021 | 1171 | 0.23 | Why? |
| Female | 48 | 2021 | 380317 | 0.22 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2018 | 449 | 0.22 | Why? |
| Nucleic Acid Hybridization | 2 | 2019 | 140 | 0.21 | Why? |
| Male | 42 | 2021 | 367725 | 0.21 | Why? |
| Child, Preschool | 11 | 2021 | 36283 | 0.21 | Why? |
| Species Specificity | 4 | 2019 | 1356 | 0.21 | Why? |
| Azithromycin | 3 | 2020 | 3943 | 0.21 | Why? |
| Locomotion | 2 | 2018 | 130 | 0.21 | Why? |
| Hydrogen-Ion Concentration | 3 | 2018 | 993 | 0.20 | Why? |
| Spotted Fever Group Rickettsiosis | 1 | 2019 | 11 | 0.20 | Why? |
| Bacillales | 1 | 2019 | 3 | 0.20 | Why? |
| Streptococcus | 1 | 2019 | 76 | 0.20 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.20 | Why? |
| Antigens, Bacterial | 2 | 2019 | 330 | 0.20 | Why? |
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 28 | 0.20 | Why? |
| Vascular Grafting | 1 | 2018 | 23 | 0.19 | Why? |
| Genomic Islands | 1 | 2018 | 26 | 0.19 | Why? |
| Ruminococcus | 1 | 2018 | 20 | 0.19 | Why? |
| Histamine | 1 | 2019 | 61 | 0.19 | Why? |
| Aerobiosis | 1 | 2018 | 12 | 0.19 | Why? |
| Enterococcus faecalis | 1 | 2019 | 126 | 0.19 | Why? |
| Delftia | 1 | 2018 | 3 | 0.19 | Why? |
| Adolescent | 19 | 2021 | 86841 | 0.19 | Why? |
| Disease Outbreaks | 5 | 2019 | 27595 | 0.19 | Why? |
| Haloferax | 1 | 2018 | 3 | 0.19 | Why? |
| Seafood | 1 | 2019 | 103 | 0.19 | Why? |
| Genome, Archaeal | 1 | 2018 | 6 | 0.19 | Why? |
| Joint Prosthesis | 1 | 2018 | 20 | 0.19 | Why? |
| Bacteroidaceae Infections | 1 | 2018 | 11 | 0.19 | Why? |
| Prevotella | 1 | 2018 | 18 | 0.18 | Why? |
| Gram-Positive Cocci | 1 | 2018 | 20 | 0.18 | Why? |
| Orientia tsutsugamushi | 1 | 2018 | 45 | 0.18 | Why? |
| Tick-Borne Diseases | 1 | 2019 | 68 | 0.18 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.18 | Why? |
| Metacarpal Bones | 1 | 2017 | 5 | 0.18 | Why? |
| Airports | 1 | 2021 | 284 | 0.18 | Why? |
| Neisseria | 1 | 2017 | 9 | 0.18 | Why? |
| Foodborne Diseases | 1 | 2019 | 89 | 0.18 | Why? |
| Automation, Laboratory | 2 | 2021 | 536 | 0.18 | Why? |
| Micrococcaceae | 1 | 2017 | 72 | 0.18 | Why? |
| Cat-Scratch Disease | 1 | 2017 | 17 | 0.18 | Why? |
| Methanobrevibacter | 1 | 2017 | 15 | 0.18 | Why? |
| Anaerobiosis | 4 | 2018 | 146 | 0.18 | Why? |
| Stomach | 1 | 2018 | 141 | 0.18 | Why? |
| Thumb | 1 | 2017 | 42 | 0.18 | Why? |
| Bartonella henselae | 1 | 2017 | 28 | 0.18 | Why? |
| Food Contamination | 1 | 2019 | 142 | 0.17 | Why? |
| Mycoplasma genitalium | 1 | 2017 | 30 | 0.17 | Why? |
| Scrub Typhus | 1 | 2018 | 68 | 0.17 | Why? |
| Chaperonin 60 | 1 | 2017 | 42 | 0.17 | Why? |
| Sexually Transmitted Diseases, Bacterial | 1 | 2017 | 26 | 0.17 | Why? |
| Western Australia | 1 | 2017 | 139 | 0.17 | Why? |
| RNA, Untranslated | 1 | 2018 | 140 | 0.17 | Why? |
| Amikacin | 1 | 2017 | 62 | 0.17 | Why? |
| Brain Abscess | 1 | 2017 | 50 | 0.17 | Why? |
| Young Adult | 18 | 2021 | 93724 | 0.17 | Why? |
| Mycoplasma Infections | 1 | 2017 | 65 | 0.17 | Why? |
| Wound Infection | 1 | 2017 | 66 | 0.17 | Why? |
| Lymphadenitis | 1 | 2017 | 53 | 0.17 | Why? |
| Microbiota | 2 | 2018 | 1240 | 0.17 | Why? |
| Mink | 1 | 2021 | 399 | 0.17 | Why? |
| Amino Acid Substitution | 2 | 2021 | 1706 | 0.17 | Why? |
| Nocardia Infections | 1 | 2017 | 37 | 0.17 | Why? |
| Aged, 80 and over | 16 | 2021 | 88759 | 0.16 | Why? |
| Tunisia | 1 | 2018 | 543 | 0.16 | Why? |
| Ascomycota | 1 | 2017 | 71 | 0.16 | Why? |
| Microbiology | 1 | 2018 | 134 | 0.16 | Why? |
| Foot | 1 | 2017 | 195 | 0.15 | Why? |
| Morocco | 1 | 2017 | 449 | 0.15 | Why? |
| Adult | 31 | 2021 | 244371 | 0.15 | Why? |
| Trench Fever | 2 | 2005 | 11 | 0.15 | Why? |
| Metagenomics | 2 | 2018 | 823 | 0.15 | Why? |
| Saudi Arabia | 4 | 2019 | 4423 | 0.15 | Why? |
| Middle Aged | 30 | 2021 | 270681 | 0.14 | Why? |
| Mass Spectrometry | 2 | 2018 | 1165 | 0.14 | Why? |
| Metagenome | 1 | 2017 | 268 | 0.14 | Why? |
| Aged | 24 | 2021 | 215776 | 0.14 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.14 | Why? |
| Biodiversity | 1 | 2018 | 546 | 0.14 | Why? |
| Laboratories | 2 | 2017 | 2858 | 0.14 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.13 | Why? |
| Body Fluids | 1 | 2018 | 451 | 0.13 | Why? |
| Temperature | 3 | 2018 | 2305 | 0.13 | Why? |
| Antitubercular Agents | 2 | 2017 | 775 | 0.13 | Why? |
| Military Personnel | 2 | 2019 | 1097 | 0.13 | Why? |
| Colon | 1 | 2018 | 669 | 0.13 | Why? |
| Respiratory Tract Infections | 3 | 2021 | 6817 | 0.13 | Why? |
| Ships | 1 | 2021 | 1046 | 0.12 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.12 | Why? |
| Animals | 10 | 2021 | 78931 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Cystic Fibrosis | 2 | 2019 | 1104 | 0.12 | Why? |
| Hydroxychloroquine | 3 | 2020 | 12447 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Intestines | 1 | 2018 | 817 | 0.11 | Why? |
| Opportunistic Infections | 1 | 2018 | 602 | 0.11 | Why? |
| Preoperative Care | 1 | 2021 | 1515 | 0.11 | Why? |
| Drug Resistance, Bacterial | 2 | 2018 | 1414 | 0.11 | Why? |
| Refugees | 1 | 2021 | 809 | 0.11 | Why? |
| Viruses | 3 | 2021 | 2238 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2018 | 1458 | 0.11 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Hospitals, University | 3 | 2017 | 4173 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Anti-Bacterial Agents | 5 | 2018 | 10083 | 0.10 | Why? |
| Switzerland | 1 | 2017 | 2738 | 0.10 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.10 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Israel | 1 | 2017 | 2751 | 0.09 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.09 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.09 | Why? |
| RNA, Bacterial | 3 | 2017 | 116 | 0.09 | Why? |
| Sequence Homology, Nucleic Acid | 2 | 2019 | 368 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Obesity, Morbid | 1 | 2018 | 1340 | 0.08 | Why? |
| Molecular Sequence Data | 2 | 2010 | 3198 | 0.08 | Why? |
| Pathology, Molecular | 1 | 2010 | 343 | 0.08 | Why? |
| Rickettsia prowazekii | 1 | 2005 | 3 | 0.08 | Why? |
| Multienzyme Complexes | 1 | 2006 | 43 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.08 | Why? |
| Typhus, Epidemic Louse-Borne | 1 | 2005 | 17 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2006 | 60 | 0.08 | Why? |
| Lice Infestations | 1 | 2005 | 39 | 0.08 | Why? |
| Immunocompromised Host | 2 | 2020 | 5150 | 0.08 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2006 | 143 | 0.07 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.07 | Why? |
| Renal Dialysis | 2 | 2019 | 4358 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Prospective Studies | 5 | 2019 | 43301 | 0.07 | Why? |
| Immunohistochemistry | 2 | 2010 | 2275 | 0.07 | Why? |
| Phenotype | 4 | 2018 | 4037 | 0.07 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.06 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.06 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.06 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.06 | Why? |
| Minor Surgical Procedures | 1 | 2021 | 24 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Retrospective Studies | 9 | 2020 | 105322 | 0.06 | Why? |
| Siphonaptera | 1 | 2001 | 21 | 0.06 | Why? |
| Bartonella Infections | 1 | 2000 | 18 | 0.06 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.05 | Why? |
| Sao Tome and Principe | 1 | 2019 | 11 | 0.05 | Why? |
| RNA, Ribosomal | 1 | 2019 | 39 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Paenibacillus | 1 | 2019 | 2 | 0.05 | Why? |
| Tuna | 1 | 2019 | 16 | 0.05 | Why? |
| Sputum | 2 | 2019 | 1720 | 0.05 | Why? |
| Perioperative Period | 1 | 2021 | 276 | 0.05 | Why? |
| Transcription, Genetic | 1 | 2006 | 1326 | 0.05 | Why? |
| Islands | 1 | 2019 | 81 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Pericardial Effusion | 1 | 2003 | 312 | 0.05 | Why? |
| Goats | 1 | 2019 | 217 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Clostridium | 1 | 2018 | 33 | 0.05 | Why? |
| Ticks | 1 | 2019 | 107 | 0.05 | Why? |
| Arthropod Vectors | 1 | 2018 | 35 | 0.05 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.05 | Why? |
| Streptococcus intermedius | 1 | 2017 | 3 | 0.05 | Why? |
| Porphyromonas endodontalis | 1 | 2017 | 3 | 0.05 | Why? |
| DNA, Archaeal | 1 | 2017 | 7 | 0.04 | Why? |
| History, 21st Century | 2 | 2017 | 1849 | 0.04 | Why? |
| Catalase | 1 | 2018 | 97 | 0.04 | Why? |
| French Guiana | 1 | 2017 | 83 | 0.04 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 393 | 0.04 | Why? |
| Foot Injuries | 1 | 2017 | 35 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| GATA2 Transcription Factor | 1 | 2017 | 13 | 0.04 | Why? |
| Leukocidins | 1 | 2017 | 47 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3633 | 0.04 | Why? |
| Comoros | 1 | 2017 | 46 | 0.04 | Why? |
| Reverse Transcription | 1 | 2021 | 673 | 0.04 | Why? |
| Exotoxins | 1 | 2017 | 54 | 0.04 | Why? |
| Empirical Research | 1 | 2017 | 72 | 0.04 | Why? |
| Nocardia | 1 | 2017 | 21 | 0.04 | Why? |
| Sugars | 1 | 2017 | 28 | 0.04 | Why? |
| Oxidoreductases | 1 | 2018 | 136 | 0.04 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Molecular Biology | 1 | 2019 | 139 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 13720 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2017 | 207 | 0.04 | Why? |
| Autoimmune Diseases | 1 | 2010 | 1996 | 0.04 | Why? |
| Molecular Typing | 1 | 2017 | 280 | 0.04 | Why? |
| Heart Valve Diseases | 1 | 2000 | 355 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.04 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 170 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2021 | 1335 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.04 | Why? |
| Antibodies, Bacterial | 1 | 2019 | 510 | 0.04 | Why? |
| Travel | 3 | 2021 | 7220 | 0.04 | Why? |
| Microbial Sensitivity Tests | 1 | 2004 | 2886 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.04 | Why? |
| Cattle | 1 | 2019 | 1336 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Injections, Intramuscular | 1 | 2017 | 800 | 0.03 | Why? |
| Endoscopy, Digestive System | 1 | 2018 | 352 | 0.03 | Why? |
| Air Travel | 1 | 2021 | 585 | 0.03 | Why? |
| One Health | 1 | 2019 | 390 | 0.03 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Nigeria | 1 | 2021 | 2292 | 0.03 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.03 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.03 | Why? |
| Serologic Tests | 2 | 2018 | 4359 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| Propionibacterium | 1 | 2011 | 5 | 0.03 | Why? |
| Genes, rRNA | 1 | 2011 | 10 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.03 | Why? |
| Colonoscopy | 1 | 2018 | 738 | 0.03 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.03 | Why? |
| Thorax | 1 | 2021 | 1873 | 0.03 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.03 | Why? |
| Religion | 1 | 2014 | 353 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Turkey | 1 | 2021 | 3937 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.03 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Cities | 1 | 2021 | 4937 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.02 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Paleodontology | 1 | 2005 | 3 | 0.02 | Why? |
| Base Sequence | 2 | 2005 | 3581 | 0.02 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.02 | Why? |
| Neoplasms | 2 | 2017 | 17251 | 0.02 | Why? |
| Lithuania | 1 | 2005 | 92 | 0.02 | Why? |
| Pediculus | 1 | 2005 | 35 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.02 | Why? |
| Dental Pulp | 1 | 2005 | 48 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Symptom Assessment | 1 | 2018 | 4967 | 0.02 | Why? |
| History, 19th Century | 1 | 2005 | 384 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.02 | Why? |
| Amoxicillin | 1 | 2003 | 98 | 0.02 | Why? |
| Paraquat | 1 | 1982 | 15 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2004 | 239 | 0.02 | Why? |
| Computer Systems | 1 | 2004 | 255 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Patient Selection | 1 | 1996 | 4560 | 0.01 | Why? |
| Public Health Surveillance | 1 | 2014 | 3129 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Ultrasonography | 1 | 1996 | 4409 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| DNA Primers | 1 | 2003 | 1170 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Kinetics | 1 | 2004 | 3238 | 0.01 | Why? |
| von Willebrand Factor | 1 | 2000 | 668 | 0.01 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Image Processing, Computer-Assisted | 1 | 2000 | 1383 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2018 | 29620 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2014 | 43792 | 0.01 | Why? |
| Gastric Lavage | 1 | 1982 | 8 | 0.00 | Why? |
| Eating | 1 | 1982 | 395 | 0.00 | Why? |
| Dose-Response Relationship, Drug | 1 | 1982 | 3776 | 0.00 | Why? |
| Gastrointestinal Diseases | 1 | 1982 | 2580 | 0.00 | Why? |
| Acute Kidney Injury | 1 | 1982 | 5762 | 0.00 | Why? |
| Prognosis | 1 | 1982 | 32490 | 0.00 | Why? |